PRESS RELEASES
CATCH UP WITH OUR LATEST PRESS RELEASES
September 10, 2025
A Letter to the STXBP1 Community
February 3, 2022
PharmaVoice profiles Capsida CEO Peter Anastasiou
Except for historical information, all of the statements, expectations, and assumptions contained in our press releases are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the development stage of our primary clinical candidates and related risks involved in drug development, clinical trials, regulation, manufacturing and commercialization; our reliance on third parties for success in certain areas of Capsida’s business; need to raise additional capital; competition; intellectual property risks; risks relating to doing business in foreign countries; and the other risk factors. We assume no obligation and do not intend to update these forward-looking statements, except as required by law.